B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 5, Pages 1479
Publisher
MDPI AG
Online
2018-05-17
DOI
10.3390/ijms19051479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
- (2017) Yuelei Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
- (2017) Hsiu-Hua Wang et al. TUMOR BIOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer
- (2016) Sophie S.W. Wang et al. Oncotarget
- KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis
- (2016) Ling-Yu Wang et al. Cell Reports
- Cellular senescence and aging: the role of B-MYB
- (2014) Sophia N. Mowla et al. AGING CELL
- SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
- (2014) M. Sinn et al. ANNALS OF ONCOLOGY
- Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis
- (2014) G. P. Nagaraju et al. CARCINOGENESIS
- SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
- (2014) Jianguo Feng et al. CURRENT PHARMACEUTICAL DESIGN
- SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
- (2013) Cesarina Giallongo et al. BMC CANCER
- Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients
- (2013) Óscar Fuster et al. LEUKEMIA RESEARCH
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis
- (2012) Hai-Yun Wang et al. Journal of Translational Medicine
- Altered expression levels of IDH2 are involved in the development of colon cancer
- (2012) QIANG LV et al. Experimental and Therapeutic Medicine
- B-Myb, Cancer, Senescence, and MicroRNAs
- (2011) I. Martinez et al. CANCER RESEARCH
- Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
- (2011) Diego F. Calvisi et al. HEPATOLOGY
- Activation of B-Myb by E2F1 in hepatocellular carcinoma
- (2008) Tomoaki Nakajima et al. HEPATOLOGY RESEARCH
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started